Last updated 2026-08-20
- Raised $10M Seed round led by Boston Scientific, 1999
- Raised $743k debt round, Nov 2022
- Raised grant led by Europa, Jun 2017
Total raised
$10.7M
Stage
—
Founded
1998
Headcount
—
HQ
Petah-Tikva, Israel
Sector
Medical Devices
Website ↗Registrar ID: 512590787 (MEL Medical Enterprises Ltd.)
About
Medical Enterprises Group is a dynamic medical device company with R&D, manufacturing, technical support, and clinical activities managed from its facility in Israel. The company focuses on developing minimally invasive therapeutic technologies, with its leading product, Synergo, providing an advanced treatment modality for non-muscle-invasive bladder cancer (NMIBC). The Synergo technology combines radiofrequency (RF) energy, chemotherapy, and hyperthermia to treat bladder tissue. The company is certified by BSI for CE mark and EN ISO 13485:2016.
Funding history · 3 rounds · $10.7M total
3 events/rounds · $10.7M Total Funding: $10.0M in Private Equity, $743K in Debt
Nov 2022
Debt Financing
$743K
pitchbook.com
Jun 2017
Grant
Undisclosed
tracxn.com
★ Europa
1999
★ Boston Scientific
Offices
Petah-Tikva, Israel · HQ / main office
Q&A
- What is MEL Medical Enterprises Ltd. (Synergo)'s primary focus?
- MEL Medical Enterprises Ltd. (Synergo) is a medical device company that develops minimally invasive therapeutic technologies, specifically for non-muscle invasive bladder cancer.
- What is the name of MEL Medical Enterprises Ltd. (Synergo)'s leading product?
- The company's leading product is Synergo RITE, which treats non-muscle invasive bladder cancer by combining radiofrequency-induced hyperthermia with chemotherapy.
- When was MEL Medical Enterprises Ltd. (Synergo) founded?
- MEL Medical Enterprises Ltd. (Synergo) was founded in 1998.
- Where is MEL Medical Enterprises Ltd. (Synergo) headquartered?
- MEL Medical Enterprises Ltd. (Synergo) is headquartered in Petah-Tikva, Israel.
- What is MEL Medical Enterprises Ltd. (Synergo)'s primary sector?
- The company's primary sector is Medical Devices.
- What is the total amount of funding raised by MEL Medical Enterprises Ltd. (Synergo) to date?
- MEL Medical Enterprises Ltd. (Synergo) has raised a total of $10,000,000.
- When did MEL Medical Enterprises Ltd. (Synergo) complete its Seed funding round?
- MEL Medical Enterprises Ltd. (Synergo) completed its Seed funding round in August 1999.
- Which investor participated in MEL Medical Enterprises Ltd. (Synergo)'s Seed funding round?
- Boston Scientific participated in MEL Medical Enterprises Ltd. (Synergo)'s Seed funding round.
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Business model
B2BB2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | synergo-medical.com/ |
|---|
Identifiers & details
| Legal name | MEL Medical Enterprises Ltd. |
|---|---|
| Founded | 1998 |
Radar intelligence
Web history (Wayback)
| Domain | synergo-medical.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512590787 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1998-01-25 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אודם 6 פתח תקווה |